Bukwang to conduct clinical trials for active isomers of thioctic acid

Published: 2009-05-29 06:57:00
Updated: 2009-05-29 06:57:00
Bukwang Pharm unveiled its plan to conduct its own clinical trials for chemically aisomers of thioctic acid as a promising new drug.

The company will initiate clinical trials after getting an approval from the Korea Food and Drug Administration.

The safety and efficacy of the new drug was a...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.